Diagnostic imaging services provider RadNet (NASDAQ:RDNT), and iCAD (NASDAQ:ICAD), a provider of AI-powered breast health solutions, announced on Tuesday that they have entered into a definitive ...

RadNet, Inc., a leader in diagnostic imaging services, has announced its acquisition of iCAD, Inc., a company specializing in AI-powered breast health solutions. This acquisition enhances DeepHealth's ...

The acquisition will unite complementary leading AI-powered cancer detection and workflow solutions focused on improving the accuracy and early detection of breast cancer The transaction is expected ...

Shares of AI-powered breast health solutions provider iCAD, Inc. (ICAD) rocketed over 67% on Wednesday morning after the company said it entered a definitive merger agreement with RadNet (RDNT).

RadNet company DeepHealth has signed a $103m deal to acquire iCAD, an AI-powered breast cancer screening company based in New Hampshire, US. The merger agreement’s terms equate to an all-stock buyout ...

Los Angeles-based RadNet Inc. announced the proposed acquisition of iCAD Inc. for approximately $100 million on April 15. The transaction is subject to approval by iCAD stockholders and other ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

LOS ANGELES and NASHUA, N.H., April 15, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT) (“RadNet”), a national leader in providing high-quality, cost-effective diagnostic imaging services and ...

Based upon RadNet’s closing price on Monday, April 14, 2025, this represents a transaction value of approximately $103 million, or approximately $3.61 per share of iCAD common stock on a fully diluted ...